KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Charles River Laboratories International (CRL) Net Income towards Common Stockholders: 2009-2024

Historic Net Income towards Common Stockholders for Charles River Laboratories International (CRL) over the last 16 years, with Dec 2024 value amounting to $10.3 million.

  • Charles River Laboratories International's Net Income towards Common Stockholders fell 20.76% to $54.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$83.5 million, marking a year-over-year decrease of 120.21%. This contributed to the annual value of $10.3 million for FY2024, which is 97.83% down from last year.
  • According to the latest figures from FY2024, Charles River Laboratories International's Net Income towards Common Stockholders is $10.3 million, which was down 97.83% from $474.6 million recorded in FY2023.
  • In the past 5 years, Charles River Laboratories International's Net Income towards Common Stockholders registered a high of $486.2 million during FY2022, and its lowest value of $10.3 million during FY2024.
  • Over the past 3 years, Charles River Laboratories International's median Net Income towards Common Stockholders value was $474.6 million (recorded in 2023), while the average stood at $323.7 million.
  • Its Net Income towards Common Stockholders has fluctuated over the past 5 years, first soared by 43.79% in 2020, then slumped by 97.83% in 2024.
  • Yearly analysis of 5 years shows Charles River Laboratories International's Net Income towards Common Stockholders stood at $365.3 million in 2020, then grew by 9.18% to $398.8 million in 2021, then grew by 21.91% to $486.2 million in 2022, then dropped by 2.39% to $474.6 million in 2023, then plummeted by 97.83% to $10.3 million in 2024.